Tag Archives: FCSC

What Made H.C. Wainwright Downgrade Fibrocell Science Inc’s Stock?

Fibrocell Science Inc (FCSC – Research Report) received a Hold rating and a $3 price target from H.C. Wainwright analyst Joseph Pantginis today. The company’s shares closed last Monday at $2.93. Pantginis commented: “Valuation and risks to price target achievement.

H.C. Wainwright Reiterates a Buy Rating on Fibrocell Science Inc (FCSC)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Fibrocell Science Inc (FCSC – Research Report), with a price target of $22. The company’s shares opened today at $2.20. Pantginis commented: “Valuation and risks

H.C. Wainwright Sticks to Its Buy Rating for Fibrocell Science Inc (FCSC)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Fibrocell Science Inc (FCSC – Research Report), with a price target of $22. The company’s shares closed yesterday at $1.85, close to its 52-week low

Analysts Offer Insights on Healthcare Companies: Fibrocell Science Inc (NYSE MKT: FCSC) and Amag Pharmaceuticals (NASDAQ: AMAG)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fibrocell Science Inc (FCSC – Research Report) and Amag Pharmaceuticals (AMAG – Research Report). Fibrocell Science Inc (FCSC) In a report released today,

H.C. Wainwright Remains a Buy on Fibrocell Science Inc (FCSC)

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Fibrocell Science Inc (NYSE MKT: FCSC), with a price target of $22. The company’s shares opened today at $1.75, equals to its 52-week low of

H.C. Wainwright Thinks Fibrocell Science Inc’s Stock is Going to Recover

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Fibrocell Science Inc (NASDAQ: FCSC) today and set a price target of $22. The company’s shares closed yesterday at $2.34, close to its 52-week low of $2.21. According to TipRanks.com,